Cancer Research Funding

Share

Cancer research saves lives and makes more time for survivors.

By investing in the research of today, Congress can help prevent, detect, and treat many of the cancers of tomorrow, creating countless moments for patients and their loved ones in the process.

Every major breakthrough in the fight against cancer has one thing in common: the research was in some way funded by the federal government's National Institutes of Health and the National Cancer Institute.

Increased funding for cancer research lengthens and saves lives and must be a top budget priority for Congress.

Take Action

Man with arms crossed, serious expression and wearing an ACS CAN polo

Sign the Petition & Tell Congress Cancer Research Funding is Essential

Congress recently jeopardized progress by cutting funding for cancer research. Sign the petition today, and let Congress know cancer advocates are calling on them to prioritize cancer research funding.

Latest Updates

March 26, 2025
National

Yesterday, the U.S. Senate voted to confirm Jay Bhattacharya, MD, PhD, as the new director of the National Institutes of Health (NIH).

March 11, 2025
National

Today, the U.S. House passed The Full-Year Continuing Appropriations and Extensions Act, 2025. It contains no increases for federal cancer research or prevention funding and significant cuts to Congressionally Directed Medical Research Programs (CDMRP), in which cancer is the largest recipient of funds.

March 10, 2025
National

“With over 2 million people in America expected to be diagnosed with cancer in 2025, now is not the time to halt investments in cancer research, prevention and early detection programs.

January 3, 2025

WASHINGTON, D.C.— January 3, 2025 — “ As the 119 th Congress convenes today, ACS CAN is urging members to keep cancer patients and survivors at the core of every health policy decision, from funding cancer research to ensuring access to quality, affordable health coverage. “Every major breakthrough in the

Cancer Research Funding Resources

The House Energy and Commerce Committee sought community feedback on potential structural and policy changes at the National Institutes of Health.  ACS CAN offered suggestions related to NCI and the proposal's impacts on cancer research. 

The Clinical Trial Modernization Act (H.R. 8412) would increase access to clinical trials by allowing clinical trial sponsors to provide financial support to patients for costs associated with their trial participation, including medical cost-sharing like copays, and non-medical expenses such as travel, parking, food and lodging.

To ensure that the research being supported today yields the cancer treatments of tomorrow, Congress must sustain and expand the support it is currently providing.